此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial (FRAME)

2026年10月30日 更新者:Kwok Yan Yan、The University of Hong Kong

Effects of "Family Resilience And Mind-body Enhancement" (FRAME) - a Mind-body Intervention for Parents With Autistic Children: A Randomised Controlled Trial

The goal of this clinical trial is to learn if a family resilience and mind-body programme called "Family Resilience And Mind-body Enhancement" (FRAME) works to support families with autistic children. The main question it aims to answer is:

- What are the effectiveness and acceptability of FRAME for families with autistic children?

Researchers will compare FRAME to a waitlist group (participants who receive the programme after the study ends) to see if FRAME makes a difference.

Participants will:

  • Attend six weekly 2-hour group sessions, each combining mind-body practices and family resilience concepts
  • Practise mindfulness exercises at home between sessions
  • Complete questionnaires before and immediately after the programme, and 3 months later

研究概览

研究类型

介入性

注册 (估计的)

114

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Jojo Yan Yan Kwok, PhD
  • 电话号码:852 3917 6644
  • 邮箱:jojoyyk@hku.hk

研究联系人备份

  • 姓名:Tsz Ying Christine Ng, MSc
  • 电话号码:852 6200 0023

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

Participants are eligible if they:

  • identify as the primary caregiver of at least one child aged 6-12 with an ASD diagnosis from a psychologist, pediatrician, or psychiatrist;
  • currently cohabit with the child;
  • provide informed consent to participate; and
  • understand and can communicate in Cantonese Chinese

Exclusion Criteria:

Individuals will be excluded if they

  • have significant medical condition(s) rendering them incapable of participating in the study; or
  • are currently receiving other therapist-led psychological intervention(s).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Family Resilience And Mind-body Enhancement" (FRAME)

Family Resilience And Mind-body Enhancement (FRAME) is a parent-focused mind-body intervention designed for parents of autistic children. Across six weekly 2hr sessions, FRAME integrates mind-body practices - which have demonstrated efficacy among families with autistic children - with Walsh's three domains of family resilience, namely belief systems, organizational patterns and communication processes. The mind-body component will be adapted from MYmind - an established mindfulness-based intervention specifically developed for children with ASD/ADHD and their parents. Each session follows a standard format: a review on home practice, guided mind-body practices and structured group discussions and activities targeting each domain of family resilience. Session content progresses sequentially across the six sessions. Between sessions, participants are encouraged to practise daily using the workbook provided.

无干预:Waitlist control

Control group will undergo intervention after completing all assessments

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Parenting stress
大体时间:From baseline (T0) to the end of treatment at 6 weeks (T1)

Parenting Stress Index - Short Form (PSI-SF)

From baseline (T0) to the end of treatment at 6 weeks (T1)
Parenting stress
大体时间:From baseline (T0) to the end of treatment at 18 weeks (T2)

Parenting Stress Index - Short Form (PSI-SF)

From baseline (T0) to the end of treatment at 18 weeks (T2)

次要结果测量

结果测量
措施说明
大体时间
Parental distress
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

21-item Depression Anxiety Stress Scale-21 (DASS-21)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Parental Well-being
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

5-item World Health Organization Well-Being Index (WHO-5)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Mindful parenting
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

31-item Interpersonal Mindfulness in Parenting Scale (IM-P)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Child emotional and behavioural and problems
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

Parent and teacher-report Strengths and Difficulties Questionnaire (SDQ)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Sibling emotional and behavioural problems (only for families with more than one child)
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

Parent-report Strengths and Difficulties Questionnaire (SDQ)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Parent-sibling relationship (only for families with more than one child)
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

Parent-report parent-child dysfunctional interaction subscale of PSI-SF

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Parent-child relationship
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

Parent-child dysfunctional interaction subscale of PSI-SF

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Marital satisfaction
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

3-item Kansas Marital Satisfaction Scale (KMS)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Family resilience
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

Walsh Family Resilience Scale (WFRS)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Family functioning
大体时间:Baseline (T0), 6 weeks (T1), 18 weeks (T2)

McMaster Family Assessment Device (FAD)

Baseline (T0), 6 weeks (T1), 18 weeks (T2)
Intervention acceptability
大体时间:Assessed at T1 (immediately post-intervention)

A 4-item self-reported program evaluation measured on a 10-point scale, assessing: (a) easiness of the program contents, (b) usefulness of the treatment, (c) overall satisfaction, and (d) likelihood to recommend the treatment to others. Higher scores indicate greater acceptability.

Assessed at T1 (immediately post-intervention)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月12日

初级完成 (估计的)

2028年7月31日

研究完成 (估计的)

2028年7月31日

研究注册日期

首次提交

2026年10月30日

首先提交符合 QC 标准的

2026年10月30日

首次发布 (实际的)

2026年11月5日

研究记录更新

最后更新发布 (实际的)

2026年11月5日

上次提交的符合 QC 标准的更新

2026年10月30日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

其他研究编号

  • EA260737
  • RG2026/2027_A_16 (其他赠款/资助编号:Alice Ho Miu Ling Nethersole Charity Foundation)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

The data supporting the findings of this study are available upon request from the principal investigator, Prof. Kwok. These data are not publicly available, as they contain information that could compromise the privacy of research participants.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅